It is important to realize that patients with sporadic CCMs could also benefit from new pharmacological treatments identified in those combined in vitro/in vivo screening assays because a substantial number of sporadic cases is caused by biallelic somatic CCM1, CCM2, or CCM3 mutations [11], [12]. Here, PDCD10 is linked to cerebrocostomandibular syndrome.